We are live on ! Find out more
ZIVO

Zivo Bioscience, Inc. Common Stock
ZIVO

Delisted

ZIVO was delisted on the 24th of November, 2023.

Back to rankings

1 hedge funds and large institutions have $10.8K invested in Zivo Bioscience, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KBFS
Kohmann Bosshard Financial Services
Ohio
+$10.8K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KBFS
1
Kohmann Bosshard Financial Services
Ohio
$10.8K +$10.8K +500 New

ZIVO Hedge Fund Activity: Q4 2024 in Review

1 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Common Stock (ZIVO) for Q4 2024, worth a combined $10.8K.

Buyers outnumbered sellers: 1 fund opened new ZIVO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Kohmann Bosshard Financial Services, opening a new position worth an estimated $10.8K.

  • 1 institutional investor held Zivo Bioscience, Inc. Common Stock (ZIVO) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $10.8K of Zivo Bioscience, Inc. Common Stock stock for Q4 2024.
  • 1 fund opened new Zivo Bioscience, Inc. Common Stock positions in Q4 2024 and 0 closed out, a net change of +1 holder.
  • The largest Zivo Bioscience, Inc. Common Stock buyer in Q4 2024 was Kohmann Bosshard Financial Services, an estimated $10.8K added.

Based on aggregated 13F filings for Q4 2024.